What kind of therapy does Medicare not cover for indefinite periods under the Bone Mass Measurement Act?

• A. Radiation therapy
• B. Glucocorticoid therapy for more than 3 months
• C. Physical therapy
• D. Hormonal therapy

Answer: (B)

Under the Bone Mass Measurement Act, Medicare does not cover glucocorticoid therapy for indefinite periods when it extends beyond three months. This is significant because glucocorticoids are known to adversely affect bone density and increase the risk of osteoporosis. After three months, the potential complications and side effects, such as bone density loss, lead to a re-evaluation of the therapy’s necessity and effectiveness, which is why coverage is limited.

Medicare aims to ensure that treatments are appropriate and necessary, and extending coverage for therapies that can contribute to long-term adverse effects on bone health, like glucocorticoid therapy, is not justifiable under this regulation. Other therapies mentioned in the choices have different guidelines and considerations under Medicare, emphasizing the unique position of glucocorticoid therapy within this specific context.